185 related articles for article (PubMed ID: 32189865)
1. Disease Severity Assessment and Short-Term Outcome in Patients with Myasthenia Gravis.
Vemuri D; Garuda BR; Gopi S; Kumar TS; Kumari UA
Ann Indian Acad Neurol; 2020; 23(2):215-219. PubMed ID: 32189865
[TBL] [Abstract][Full Text] [Related]
2. Clinical Profile and Quality of Life in Myasthenia Gravis Using MGQOL15 R(Hindi): An Indian Perspective.
Majigoudra G; Duggal AK; Chowdhury D; Koul A; Todi VK; Roshan S
Ann Indian Acad Neurol; 2023; 26(4):441-446. PubMed ID: 37970285
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of outcome measures for myasthenia gravis subgroups.
Luo Y; Dong X; Peng Y; Cui B; Yan C; Jin W; Li Y; Zhou R; Huang K; Yang H
J Clin Neurosci; 2021 Sep; 91():270-275. PubMed ID: 34373039
[TBL] [Abstract][Full Text] [Related]
4. Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients.
Mihalache OA; Vilciu C; Petrescu DM; Petrescu C; Manea MC; Ciobanu AM; Ciobanu CA; Popa-Velea O; Riga S
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256317
[No Abstract] [Full Text] [Related]
5. Gender differences in clinical outcomes in myasthenia gravis: A prospective cohort study.
Thomsen JLS; Vinge L; Harbo T; Andersen H
Muscle Nerve; 2021 Nov; 64(5):538-544. PubMed ID: 34036597
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
Howard JF; Bril V; Vu T; Karam C; Peric S; De Bleecker JL; Murai H; Meisel A; Beydoun SR; Pasnoor M; Guglietta A; Van Hoorick B; Steeland S; T'joen C; Utsugisawa K; Verschuuren J; Mantegazza R;
Front Neurol; 2023; 14():1284444. PubMed ID: 38318236
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
8. QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis.
Howard JF; Freimer M; O'Brien F; Wang JJ; Collins SR; Kissel JT;
Muscle Nerve; 2017 Aug; 56(2):328-330. PubMed ID: 28010051
[TBL] [Abstract][Full Text] [Related]
9. The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
Burns TM; Conaway M; Sanders DB;
Neurology; 2010 May; 74(18):1434-40. PubMed ID: 20439845
[TBL] [Abstract][Full Text] [Related]
10. Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study.
Brandsema JF; Ginsberg M; Hoshino H; Mimaki M; Nagata S; Rao VK; Ruzhansky K; Suresh N; Tiongson E; Yamanouchi H; Frick G; Hicks E; Liao S; Howard JF;
Pediatr Neurol; 2024 Jul; 156():198-207. PubMed ID: 38810600
[TBL] [Abstract][Full Text] [Related]
11. [Investigation and analysis of health-related quality of life in myasthenia gravis patients with myasthenia gravis quality of life-15 Chinese version].
Miao XH; Lian ZY; Liu J; Chen HX; Shi ZY; Zhou HY; Yang R
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):514-520. PubMed ID: 29930422
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.
de Meel RHP; Barnett C; Bril V; Tannemaat MR; Verschuuren JJGM
J Neuromuscul Dis; 2020; 7(3):297-300. PubMed ID: 32250313
[TBL] [Abstract][Full Text] [Related]
13. A new and easily used modified myasthenia gravis score.
Sathirapanya P; Wiputhanuphongs K; Liabsuetrakul T; Khanittanuphong P; Keeratichananont W
Neuromuscul Disord; 2020 Aug; 30(8):656-660. PubMed ID: 32771266
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I;
Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in 188 patients with myasthenia gravis in China.
Yang Y; Zhang M; Guo J; Ma S; Fan L; Wang X; Li C; Guo P; Wang J; Li H; Li Z
Int J Neurosci; 2016; 126(5):455-62. PubMed ID: 26000922
[TBL] [Abstract][Full Text] [Related]
16. Promising efficacy of Low-Dose rituximab in Muscle specific kinase antibody positive Myasthenia Gravis.
Yang X; Zhang W; Chang X; Li Z; Du R; Guo J
Neurosci Lett; 2024 Jan; 818():137561. PubMed ID: 37984485
[TBL] [Abstract][Full Text] [Related]
17. Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
Regnault A; Morel T; de la Loge C; Mazerolle F; Kaminski HJ; Habib AA
Neurol Ther; 2023 Oct; 12(5):1573-1590. PubMed ID: 37166675
[TBL] [Abstract][Full Text] [Related]
18. Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis.
Katyal N; Narula N; Govindarajan R
J Neuromuscul Dis; 2021; 8(2):287-294. PubMed ID: 33325394
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study.
Howard JF; Vu T; Mantegazza R; Kushlaf H; Suzuki S; Wiendl H; Beasley KN; Liao S; Meisel A;
Muscle Nerve; 2024 May; 69(5):556-565. PubMed ID: 38380691
[TBL] [Abstract][Full Text] [Related]
20. Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
Howard JF; Nowak RJ; Wolfe GI; Freimer ML; Vu TH; Hinton JL; Benatar M; Duda PW; MacDougall JE; Farzaneh-Far R; Kaminski HJ; ; Barohn R; Dimachkie M; Pasnoor M; Farmakidis C; Liu T; Colgan S; Benatar MG; Bertorini T; Pillai R; Henegar R; Bromberg M; Gibson S; Janecki T; Freimer M; Elsheikh B; Matisak P; Genge A; Guidon A; David W; Habib AA; Mathew V; Mozaffar T; Hinton JL; Hewitt W; Barnett D; Sullivan P; Ho D; Howard JF; Traub RE; Chopra M; Kaminski HJ; Aly R; Bayat E; Abu-Rub M; Khan S; Lange D; Holzberg S; Khatri B; Lindman E; Olapo T; Sershon LM; Lisak RP; Bernitsas E; Jia K; Malik R; Lewis-Collins TD; Nicolle M; Nowak RJ; Sharma A; Roy B; Nye J; Pulley M; Berger A; Shabbir Y; Sachdev A; Patterson K; Siddiqi Z; Sivak M; Bratton J; Small G; Kohli A; Fetter M; Vu T; Lam L; Harvey B; Wolfe GI; Silvestri N; Patrick K; Zakalik K; Duda PW; MacDougall J; Farzaneh-Far R; Pontius A; Hoarty M
JAMA Neurol; 2020 May; 77(5):582-592. PubMed ID: 32065623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
